C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression

Snehalata A Pawar1, Tapasree Roy Sarkar, Kuppusamy Balamurugan

  • 1Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.

Insights

CCAAT/enhancer binding protein delta (C/EBPdelta) promotes tumor suppression by increasing Cdc27, which degrades cyclin D1. This reveals a new mechanism for C/EBPdelta

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • CCAAT/enhancer binding protein delta (C/EBPdelta) is a transcription factor with known tumor suppressor functions.
  • The precise molecular mechanisms underlying C/EBPdelta's tumor suppressor activity remain largely unelucidated.
  • Understanding these mechanisms is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which C/EBPdelta exerts its tumor suppressor function.
  • To investigate the role of C/EBPdelta in regulating cell cycle proteins and the anaphase promoting complex/cyclosome (APC/C).
  • To determine if Cdc27, a subunit of APC/C, has potential tumor suppressor activity.

Main Methods:

  • Utilized C/EBPdelta knockout mouse embryo fibroblasts (MEFs) to assess protein level changes.
  • Employed gene silencing techniques (siRNA) in MCF-10A breast epithelial cells to study the effects of C/EBPdelta, Cdc27, and Cdh1.
  • Analyzed protein expression levels of key cell cycle regulators including cyclin D1, cyclin B1, Skp2, and Plk-1.
  • Investigated the degradation pathways of cyclin D1, comparing SCF and APC/C mediated ubiquitination.

Main Results:

  • C/EBPdelta induces the expression of Cdc27 (APC3), a subunit of the APC/C complex.
  • Induced Cdc27 leads to polyubiquitination and degradation of the pro-oncogenic cyclin D1.
  • C/EBPdelta also down-regulates cyclin B1, Skp2, and Plk-1.
  • Reduced Cdc27 levels were observed in C/EBPdelta knockout MEFs, correlating with increased cyclin D1.
  • Silencing C/EBPdelta, Cdc27, or Cdh1 in breast cells increased cyclin D1.
  • Cdc27 expression is downregulated in several breast cancer cell lines, suggesting its role as a tumor suppressor.
  • Cdc27 mediates an alternative degradation pathway for cyclin D1 via APC/C.

Conclusions:

  • C/EBPdelta functions as a tumor suppressor by upregulating Cdc27, which targets cyclin D1 for degradation.
  • Cdc27 itself may act as a tumor suppressor due to its downregulation in breast cancer cells.
  • These findings reveal a novel regulatory role for APC/C in controlling cyclin D1 stability and highlight C/EBPdelta's mechanism in cell cycle regulation.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...